U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2745127451Bergamot and Cardio-Metabolic Risk FactorsCompletedNo Results AvailableDyslipidemiaDietary Supplement: Bergamot-derived producthttps://ClinicalTrials.gov/show/NCT02205567
2745227452Omnitram Pharmacokinetic Study In Healthy VolunteersCompletedNo Results AvailablePainDrug: Omnitram|Drug: Tramadol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02205554
2745327453Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHURecruitingNo Results AvailableHemolytic Uremic Syndrome of ChildhoodDrug: Eculizumab|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02205541
2745427454A Study of Once-Daily RO6811135 in Patients With Type 2 Diabetes Inadequately Controlled With MetforminRecruitingNo Results AvailableDiabetes Mellitus, Type 2Drug: Liraglutide|Drug: Placebo QD|Drug: RO6811135https://ClinicalTrials.gov/show/NCT02205528
2745527455An Open Label, Single-Centre, Phase II Study of Everolimus With EBRT for the Treatment of mNET Liver MetastasisNot yet recruitingNo Results AvailableCarcinoma, NeuroendocrineDrug: Everolimushttps://ClinicalTrials.gov/show/NCT02205515
2745627456Lidocaine as Local Anesthetics in Children Under Ketamine SedationRecruitingNo Results AvailableConscious Sedation Failure During Procedure|Analgesia|AnesthesiaDrug: Lidocaine|Drug: Normal salinehttps://ClinicalTrials.gov/show/NCT02205502
2745727457Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADAActive, not recruitingNo Results AvailableRelapsing-remitting Multiple SclerosisDrug: Alemtuzumab GZ402673|Drug: cetirizine|Drug: ranitidine|Drug: methylprednisolone|Drug: methylprednisolone|Drug: aciclovir|Drug: esomeprazole|Drug: ibuprofen|Drug: paracetamolhttps://ClinicalTrials.gov/show/NCT02205489
2745827458A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 StudyTerminatedNo Results AvailableHypertrophic Scars Resulting From Prior Breast Scar Revision SurgeryDrug: PF-06473871|Drug: PF-06473871https://ClinicalTrials.gov/show/NCT02205476
2745927459KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach CancerWithdrawnNo Results AvailableEsophageal Cancer|Stomach CancerDrug: KD019https://ClinicalTrials.gov/show/NCT02205463
2746027460Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of SabadellNot yet recruitingNo Results AvailablePrader-Willi SyndromeDrug: Recombinant Somatropinhttps://ClinicalTrials.gov/show/NCT02205450
2746127461Novel Candidate Genes for Treatment Response to Antipsychotics in SchizophreniaRecruitingNo Results AvailableSchizophreniahttps://ClinicalTrials.gov/show/NCT02205437
2746227462Cognition And Neocortical Volume After StrokeActive, not recruitingNo Results AvailableIschaemic Stroke|Alzheimer's Disease|Vascular Dementiahttps://ClinicalTrials.gov/show/NCT02205424
2746327463Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart TransplantationRecruitingNo Results AvailableHeart Failure|Cardiac Failure|Congestive Heart Failure|Heart Failure, Left-sidedDevice: HeartAssist 5® VAD System|Device: Control VADhttps://ClinicalTrials.gov/show/NCT02205411
2746427464Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab TherapyRecruitingNo Results AvailableSquamous Cell Carcinoma of Head and Neck,|Metastatic Colorectal CancerDrug: INC280|Drug: cetuximabhttps://ClinicalTrials.gov/show/NCT02205398
2746527465Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb AmputationRecruitingNo Results AvailableNeuroma|Neuroma Amputation|PainProcedure: Targeted Muscle Reinnervation|Procedure: Traction Neurectomyhttps://ClinicalTrials.gov/show/NCT02205385
2746627466Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic NephropathyCompletedNo Results AvailableDiabetic NephropathyDrug: MT-3995|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02205372
2746727467AdaptResponse Clinical TrialRecruitingNo Results AvailableHeart Failure With Left Bundle Branch BlockDevice: aCRT ON|Device: aCRT OFFhttps://ClinicalTrials.gov/show/NCT02205359
2746827468Urinary Leukotriene E4 Levels in Children With Obstructive Sleep ApneaRecruitingNo Results AvailableObstructive Sleep Apneahttps://ClinicalTrials.gov/show/NCT02205346
2746927469A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal AntibodiesRecruitingNo Results AvailableAdvanced Solid Tumors|Aggressive B-cell LymphomasBiological: MEDI6469/tremelimumab|Biological: MEDI6469/MEDI4736|Biological: MEDI6469/rituximab|Biological: MEDI6469https://ClinicalTrials.gov/show/NCT02205333
2747027470A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy VolunteersRecruitingNo Results AvailablePharmacokineticsBiological: DRL_PG|Biological: Pegfilgrastim Form A|Biological: Pegfilgrastim Form Bhttps://ClinicalTrials.gov/show/NCT02205320
2747127471A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior ResectionRecruitingNo Results AvailableRectal Cancer|Rectosigmoid CancerDevice: PINPOINT|Device: SPY Elitehttps://ClinicalTrials.gov/show/NCT02205307
2747227472Osteopathic Treatment and Deep Vein Thrombosis (DVT)RecruitingNo Results AvailableDeep Vein Thrombosis (DVT)Other: Osteopathic Treatmenthttps://ClinicalTrials.gov/show/NCT02205294
2747327473Partners in Health: A Couples-based Approach to Obesity PreventionRecruitingNo Results AvailableObesityBehavioral: Lifestyle Interventionhttps://ClinicalTrials.gov/show/NCT02205281
2747427474Near Infrared Spectroscopy Neurofeedback Training for ADHDRecruitingNo Results AvailableAttention Deficit/Hyperactivity DisorderProcedure: Near infrared spectroscopy neurofeedback traininghttps://ClinicalTrials.gov/show/NCT02205268
2747527475BACE Trial Substudy 2 - The Pharmaco-economic Impact of the Azithromycin InterventionRecruitingNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: Azithromycin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02205255
2747627476BACE Trial Substudy 1 - Physical Activity as a Crucial Patient Reported Outcome in COPDRecruitingNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: Azithromycin|Device: Dynaport®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02205242
2747727477Compounded Pain Preparation Absorption StudySuspendedNo Results AvailablePainDrug: Multi-ingredient, topical compounded medicationshttps://ClinicalTrials.gov/show/NCT02205229
2747827478Can tDCS Enhance Efficacy of Rehabilitative Intervention for Freezing of Gait in Parkinson's Disease?RecruitingNo Results AvailableParkinson DiseaseDevice: Active tDCS|Device: Sham tDCS|Behavioral: Rehabilitation Therapyhttps://ClinicalTrials.gov/show/NCT02205216
2747927479Youth Mayo Clinic Anxiety Coach Randomized Controlled TrialNot yet recruitingNo Results AvailableAnxietyDevice: Mayo Clinic Anxiety Coachhttps://ClinicalTrials.gov/show/NCT02205203
2748027480to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and RosuvastatinCompletedNo Results AvailableHypertensionDrug: Fimasartan|Drug: Rosuvastatin|Drug: Fimasartan/Rosuvastatin combinationhttps://ClinicalTrials.gov/show/NCT02205190

* Görseller ve İçerik tekif hakkına sahip olabilir